Tuberculosis Diagnosis

These tests detect immune sensitization to Mycobacterium tuberculosis rather than directly demonstrating bacteria in a lesion or specimen. Their results can indicate infection, but they do not by themselves establish whether disease is active. Clinicians therefore interpret immune-test findings alongside medical history, examination, chest radiography, and microbiological evidence when distinguishing latent infection from active tuberculosis.

Molecular tests can rapidly identify bacterial DNA and, on some platforms, detect mutations associated with drug resistance. Culture provides an important reference method for confirming infection, although it is not the same type of evidence as a rapid molecular result. Using both approaches can support case confirmation while helping guide antimicrobial selection when resistance is detected.

Sputum microscopy provides direct examination of a respiratory specimen for evidence associated with pulmonary infection, while chest radiography reveals abnormalities in the lungs that may support clinical assessment. Neither result replaces the full diagnostic evaluation. Their value comes from combining anatomical, specimen-based, and clinical information to strengthen interpretation of suspected pulmonary disease.

Assessment begins with medical history and physical examination, followed by tests selected to clarify infection and disease status. Immune-based testing may address sensitization, whereas chest radiography and sputum-based methods can provide evidence related to pulmonary infection. Molecular testing and culture add confirmation and, in some cases, information relevant to antimicrobial choice.

Diagnosis is particularly important when clinicians must distinguish latent infection from active disease, confirm a case, or select appropriate antimicrobial treatment. Establishing active disease also has broader public-health relevance because timely identification can help limit transmission. The combined results support decisions in both individual clinical care and tuberculosis-control activities.

Different tests contribute different biological evidence: immune assays reflect host sensitization, imaging shows radiographic findings, microscopy examines sputum, and molecular methods detect bacterial DNA. Culture remains an important reference method, while some molecular platforms also identify drug-resistance mutations. This progression from host response to organism and resistance information helps connect diagnosis with antimicrobial selection.